Press Release
Category Added in a WPeMatico Campaign
-
REI Awarded Position on MDA’s Prestigious SHIELD Contract Vehicle Supporting Golden Dome Homeland Defense Initiative
STERLING, Va., Dec. 17, 2025 /PRNewswire/ — REI Systems, a technology service provider with 36 years of delivering reliable, effective,…
Read More » -
Salt Security Outpaces API Security Market with “12 Months of Innovation” in 2025, Delivering a New API and AI Security Breakthrough Every Month
Holiday-themed year-in-review highlights a dozen launches, partnerships, and research milestones that redefined the API fabric and API action layer in…
Read More » -
Nona Biosciences and Valink Therapeutics Form Strategic Alliance to Accelerate Novel Biologics Discovery
CAMBRIDGE, Mass., Dec. 17, 2025 /PRNewswire/ — Nona Biosciences (“Nona”), a global biotechnology company providing integrated solutions for biological drug…
Read More » -
UniUni Closes Out Transformative 2025 with Record Growth, Major Partnerships, and Industry Recognition
Milestones Include Series D Funding, Geographic Expansion and Significant Volume Growth RICHMOND, BC, Dec. 17, 2025 /PRNewswire/ — UniUni, a…
Read More » -
ONE Bow River Announces Strategic Investment in LEAP to Accelerate Development of Next-Generation Launch Systems
COLORADO SPRINGS, Colo., Dec. 17, 2025 /PRNewswire/ — ONE Bow River National Defense Fund (“ONE Bow River”) today announced a…
Read More » -
Guavy Launches iOS App: AI-Powered Market Sentiment and Signals for Cryptocurrency Traders
AI-powered sentiment signals give everyday traders the same edge institutions use. Delivered as clear, data-driven signals. CALGARY, AB, Dec. 17,…
Read More » -
Award-Winning AR: RayNeo X3 Pro, selected as TIME Best Invention of 2025, launches globally Dec 17
LOS ANGELES, Dec. 17, 2025 /PRNewswire/ — RayNeo announced the December 17 global launch of its flagship RayNeo X3 Pro…
Read More » -
MEDI&GENE Announces Catalyze Agreement with Lilly to Advance Next-Generation Obesity Therapeutics
SEOUL, South Korea, Dec. 17, 2025 /PRNewswire/ — MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it…
Read More » -
Strategic Clarity: Acuity’s Neil Ashe Named 2025 EdisonReport Person of the Year
NASHVILLE, Tenn., Dec. 17, 2025 /PRNewswire/ — EdisonReport is thrilled to name Neil Ashe, Chairman, President, and CEO of Acuity (AYI) as…
Read More »